Merck's U.K. group has raised its level of play in an industry-wide competition for the attention of physicians as they use the Internet.
A survey of so-called health activists by Extrovertic and WEGO Health found that many patients with multiple sclerosis have an "insatiable appetite" for updated information
Tired of sifting through FDA warning letters for ideas about online-advertising boundaries? You're in luck. The Federal Trade Commission has issued new rules for social media and mobile ads.
Boehringer Ingelheim has expanded its reach in the world of digital healthcare via a new collaboration with the patient-focused social networking outfit PatientsLikeMe. The alliance is expected to "enhance" PatientsLikeMe's online community for idiopathic pulmonary fibrosis, an orphan lung disease without a known cause or cure.
Pharma now has another hint about FDA's attitudes toward social media. In a recent warning letter to supplement maker AMARC Enterprises, FDA took issue with the company's use of Facebook's "Like" feature. Apparently, the company "Liked" a questionable user testimonial--and the agency didn't like it.
With more than 1 billion users plugged in, Facebook has huge potential to have a real impact on science and public health, beyond just a marketing platform for biotech and pharma companies.
As flu infiltrates our homes and workplaces, researchers have developed a computer-based method of tracking Twitter posts that could alert the public to sickness faster than official health reports with greater accuracy than existing online tools.
Twitter has found a lukewarm reception among European Union countries' healthcare regulators, yet the U.K.'s Medical and Healthcare products Regulatory Agency (MHRA) has recently stepped up its efforts to reach the growing number of people on the social networking sites.
Advocates have set out to unlock some of the mysteries of an extremely rare genetic disease--with the help of social media.
Boehringer Ingelheim has rolled out a new blog as the German drugmaker travels yet another avenue of social media. The company has tapped just about every major social media platform and in September launched the online pharma game "Syrum" on Facebook.